CASI Pharmaceuticals, Inc. Contracts & Agreements

Agreement and Plan of Merger, dated January 31, 2023 by and between CASI Pharmaceuticals, Inc. and CASI Pharmaceuticals Holdings, Inc (Filed With SEC on January 31, 2023)

Equity Transfer Agreement between CASI Biopharmaceuticals (Wuxi) Co., Ltd. and Shenzhen Jiadao Gongcheng Equity Investment Fund (Limited Partnership) dated September 22, 2022 (Filed With SEC on November 14, 2022)

Promissory Note issued by the Registrant to East West Bank, dated May 23, 2022 (Filed With SEC on August 12, 2022)

Sublicense Agreement between the Registrant and Beijing Tianshi Tongda Pharmaceuticals Technology Co., Ltd, dated May 23, 2022 (Filed With SEC on August 12, 2022)

Business Loan Agreement between the Registrant and East West Bank, dated May 23, 2022 (Filed With SEC on August 12, 2022)

Commercial Security Agreement between the Registrant and East West Bank, dated May 23, 2022 (Filed With SEC on August 12, 2022)

Commercial Pledge Agreement between the Registrant and East West Bank, dated May 23, 2022 (Filed With SEC on August 12, 2022)

Amendment No. 1 to Employment Agreement (Filed With SEC on December 10, 2021)

First Amendment to Change in Control Agreement (Filed With SEC on December 10, 2021)

Common Stock Sales Agreement (the Sales Agreement) by and between CASI Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC dated October 29, 2021 (Filed With SEC on October 29, 2021)

Form of CASI Pharmaceuticals Inc. Performance-Contingent 2021 Long-Term Incentive Plan Non-Qualified Stock Option Grant Agreement (for Optionees in China) (Filed With SEC on August 12, 2021)

Form of CASI Pharmaceuticals Inc. 2021 Long-Term Incentive Plan Non-Qualified Stock Option Grant Agreement (for Optionees in China) (Filed With SEC on August 12, 2021)

Form of CASI Pharmaceuticals Inc. Performance-Contingent 2021 Long-Term Incentive Plan Non-Qualified Stock Option Grant Agreement (for Optionees in the US) (Filed With SEC on August 12, 2021)

Form of CASI Pharmaceuticals Inc. 2021 Long-Term Incentive Plan Non-Qualified Stock Option Grant Agreement (for Optionees in the US) (Filed With SEC on August 12, 2021)

License and Development Agreement for CB-5339 by and between Cleave Therapeutics, Inc. and CASI Pharmaceuticals, Inc. dated March 5, 2021 (Filed With SEC on May 13, 2021)

Description of Common Stock (Filed With SEC on March 30, 2021)

License Agreement, dated as of September 17, 2014, by and between CASI Pharmaceuticals, Inc. and Spectrum Pharmaceuticals, Inc (Filed With SEC on March 30, 2021)

License Agreement, dated as of September 17, 2014, by and between CASI Pharmaceuticals, Inc. and Spectrum Pharmaceuticals Cayman, L.P (Filed With SEC on March 30, 2021)

License Agreement, dated as of September 17, 2014, by and between CASI Pharmaceuticals, Inc. and Talon Therapeutics, Inc (Filed With SEC on March 30, 2021)

Exhibit 1.1Underwriting Agreement, dated March 24, 2021, between CASI and Oppenheimer & Co. Inc (Filed With SEC on March 26, 2021)

Supplementary Agreement to the Exclusive License Agreement effective as of September 29, 2020 (Filed With SEC on November 9, 2020)

Investment Agreement by and between Juventas Cell Therapy Ltd and CASI Biopharmaceuticals (WUXI) Co., Ltd. effective as of September 22, 2020 (Filed With SEC on November 9, 2020)

Exhibit 1.1Underwriting Agreement dated July 22, 2020, between the Company and Oppenheimer & Co. Inc (Filed With SEC on July 24, 2020)

Description of Common Stock (Filed With SEC on March 16, 2020)

Contract for Assignment of the Right to the Use of the State-owned Construction Land (no. 3202842019CR0019) dated November 15, 2019 (Filed With SEC on March 16, 2020)

Exclusive License Agreement by and between CASI Pharmaceuticals, Inc. and Juventas Cell Therapy Ltd. effective June 15, 2019 (Filed With SEC on August 9, 2019)

Investment Agreement in respect of Juventas Cell Therapy Ltd. executed June 15, 2019 (Filed With SEC on August 9, 2019)

Open Market Sale AgreementSM by and between CASI Pharmaceuticals, Inc. and Jefferies LLC dated July 19, 2019 (Filed With SEC on July 19, 2019)

Amendment No. 1 to Common Stock Sales Agreement by and between CASI Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC dated July 19, 2019 (Filed With SEC on July 19, 2019)

Form of CASI Pharmaceuticals, Inc. Performance-Contingent 2011 Long-Term Incentive Plan Non-Qualified Stock Option Grant Agreement (for Optionees in China) (Filed With SEC on May 15, 2019)

Form of CASI Pharmaceuticals, Inc. 2011 Long-Term Incentive Plan Non-Qualified Stock Option Grant Agreement (for Optionees in China) (Filed With SEC on May 15, 2019)

Form of CASI Pharmaceuticals, Inc. Performance-Contingent 2011 Long-Term Incentive Plan Non-Qualified Stock Option Grant Agreement (for Optionees in the US) (Filed With SEC on May 15, 2019)

Form of CASI Pharmaceuticals, Inc. 2011 Long-Term Incentive Plan Non-Qualified Stock Option Grant Agreement (for Optionees in the US) (Filed With SEC on May 15, 2019)

Exclusive Distribution Agreement, effective as of March 5, 2019, by and among CASI Pharmaceuticals, Inc., China Resources Guokang Pharmaceuticals Co., Ltd. and CASI (Beijing)... (Filed With SEC on May 15, 2019)

Offer Letter from CASI Pharmaceuticals, Inc. to Dr. He dated March 22, 2019, effective April 2, 2019 (Filed With SEC on May 15, 2019)

Memorandum of Understanding, dated November 16, 2018, by and between Management Committee of Wuxi Hui-shan Economic Development Zone and CASI Pharmaceuticals, Inc (Filed With SEC on March 29, 2019)

Investment Agreement, dated November 16, 2018, by and between Administrative Committee of Wuxi Huishan Economic Development Zone, Jiangsu Province and CASI Pharmaceuticals, Inc (Filed With SEC on March 29, 2019)

Supplementary Agreement, dated November 16, 2018, by and between Administrative Committee of Wuxi Huishan Economic Development Zone, Jiangsu Province and CASI Pharmaceuticals, Inc (Filed With SEC on March 29, 2019)

Shareholders Agreement, dated November 16, 2018, between CASI Pharmaceuticals, Inc. and Wuxi Jintou Huicun Investment Enterprise (Limited Partnership) (Filed With SEC on March 29, 2019)

Lease Contract, by and between Wuxi Huishan New City Life Science & Technology Industry Development Co., Ltd. and CASI Pharmaceuticals, Inc (Filed With SEC on March 29, 2019)

Joint Venture Contract on Establishment of CASI (Wuxi) Pharmaceuticals Co. Ltd. by and between CASI Pharmaceuticals, Inc. and Wuxi Jintou Huicun Investment Enterprise Limited... (Filed With SEC on March 29, 2019)

Labor Contract, effective as of September 1, 2018, between CASI (Beijing) Pharmaceuticals, Inc. and Wei (Larry) Zhang (Filed With SEC on March 29, 2019)

Employment Agreement, effective as of September 28, 2018, between the Company and George Chi (Filed With SEC on October 24, 2018)

Form of Warrant (Filed With SEC on September 14, 2018)

Form of Securities Purchase Agreement (Filed With SEC on September 14, 2018)

Asset Purchase Agreement, dated as of January 26, 2018, by and between CASI Pharmaceuticals, Inc. and Sandoz Inc (Filed With SEC on March 29, 2018)

Form of Warrant (Filed With SEC on March 23, 2018)

Form of Securities Purchase Agreement (Filed With SEC on March 23, 2018)

Common Stock Sales Agreement (the Sales Agreement) by and between CASI Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC dated February 23, 2018 (Filed With SEC on February 23, 2018)

Third Amendment to Secured Promissory Note, dated as of December 20, 2017, by and between the Company and Talon Therapeutics, Inc (Filed With SEC on December 22, 2017)

Engagement Letter, dated as of October 12, 2017, by and between CASI Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on October 19, 2017)

Form of Common Stock Purchase Warrant (Filed With SEC on October 19, 2017)

Form of Wainwright Warrant (Filed With SEC on October 19, 2017)

Form of Stock Purchase Agreement (Filed With SEC on October 19, 2017)

employmentagreement (Filed With SEC on August 14, 2017)

SECOND AMENDMENT TO SECURED PROMISSORY NOTE (Filed With SEC on December 16, 2016)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 13, 2015)

FIRST AMENDMENT TO SECURED PROMISSORY NOTE (Filed With SEC on October 1, 2015)

Confidential Materials omitted andfiled separately with the Securities and Exchange Commission. Triple asterisks denote omissions. LICENSE AGREEMENT (Filed With SEC on November 14, 2014)

Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Triple asterisks denote omissions. LICENSE AGREEMENT (Filed With SEC on November 14, 2014)

CERTIFICATE OF DESIGNATIONS OF series A preferred stock Of CASIPHARMACEUTICALS, INC. (Filed With SEC on September 19, 2014)

SECURED PROMISSORY NOTE (Filed With SEC on September 19, 2014)

INVESTMENT AGREEMENT (Filed With SEC on September 19, 2014)

employmentagreement (Filed With SEC on May 15, 2013)

ANNEX 1 INDEMNIFICATION AND CONTRIBUTION (Filed With SEC on March 6, 2013)

FORM OF COMMON STOCK PURCHASE WARRANT entremed,inc. (Filed With SEC on March 6, 2013)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on March 6, 2013)

EntreMed, Inc. / 9640Medical Center Drive / Rockville, MD 20850 Phone ###-###-#### / 240.864.2601fax (Filed With SEC on April 3, 2012)

CONVERTIBLE NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on January 26, 2012)

STANDBY EQUITY DISTRIBUTION AGREEMENT (Filed With SEC on June 28, 2011)

Third Amendment to Lease Agreement (Filed With SEC on March 30, 2011)

EMPLOYMENT AGREEMENT (Filed With SEC on March 30, 2011)

SEPARATION AGREEMENT AND GENERAL RELEASE (Filed With SEC on March 30, 2011)

THISEXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIALTREATMENT REQUEST PURSUANT TO RULE 24b-2. REDACTEDMATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY... (Filed With SEC on November 12, 2010)

FORMOF COMMONSTOCK PURCHASE WARRANT ENTREMED,INC. (Filed With SEC on September 10, 2010)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on September 10, 2010)

WHARTON CAPITALMARKETS LLC (Filed With SEC on April 16, 2010)

STOCKPURCHASE AGREEMENT (Filed With SEC on April 16, 2010)

WHARTONCAPITAL MARKETS LLC (Filed With SEC on February 4, 2010)

STOCKPURCHASE AGREEMENT (Filed With SEC on February 4, 2010)

Exhibit 1.1 WHARTON CAPITALMARKETS LLC (Filed With SEC on January 12, 2010)

Exhibit10.1 STOCKPURCHASE AGREEMENT (Filed With SEC on January 12, 2010)

Amendment to Lease Agreement (Filed With SEC on March 13, 2009)

EMPLOYMENT AGREEMENT (Filed With SEC on March 13, 2009)

EMPLOYMENT AGREEMENT (Filed With SEC on August 6, 2008)

EMPLOYMENT AGREEMENT (Filed With SEC on May 2, 2008)

WARRANT TO PURCHASE 125,000 SHARES OF COMMON STOCK (Filed With SEC on November 8, 2007)

WARRANT TO PURCHASE 62,500 SHARES OF COMMON STOCK (Filed With SEC on November 8, 2007)

LOAN AND SECURITY AGREEMENT (Filed With SEC on November 8, 2007)

PROMISSORY NOTE (Filed With SEC on November 8, 2007)

CHANGE IN CONTROL AGREEMENT (Filed With SEC on April 17, 2007)

[ENTREMED LETTERHEAD] (Filed With SEC on April 17, 2007)

EntreMed, Inc. 2001 Long-Term Incentive Plan Non-Qualified Stock Option Grant Agreement (Filed With SEC on April 17, 2007)

ENTREMED, INC. 2001 LONG-TERM INCENTIVE PLAN, AS AMENDED (Filed With SEC on August 9, 2006)

EMPLOYMENT AGREEMENT (Filed With SEC on June 6, 2006)

ELAN PHARMA INTERNATIONAL LIMITED (Filed With SEC on May 10, 2006)

RESEARCH, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on May 10, 2006)

ENTREMED, INC. (Filed With SEC on February 8, 2006)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 8, 2006)

AGREEMENT AND PLAN OF MERGER among: EntreMed, Inc. a Delaware corporation; E.M.K. Sub, Inc. a Delaware corporation; Miikana Therapeutics Inc. a Delaware corporation; and... (Filed With SEC on December 29, 2005)

License Agreement By and between EntreMed, Inc. and Celgene Corporation. (Filed With SEC on May 10, 2005)

[EntreMed Letterhead] (Filed With SEC on March 11, 2005)

APPENDIX A (Filed With SEC on March 11, 2005)

EntreMed, Inc. 2001 Long-Term Incentive Plan Non-QUALIFIED Stock Option Grant Agreement (Filed With SEC on February 23, 2005)

Optionee: OptioneeGrant: Grant_AmtNonqualified: NSO_AmtExercise Price: $Share_Price EntreMed, Inc. 2001 Long-Term Incentive Plan Non-QUALIFIED Stock Option Grant Agreement (Filed With SEC on February 23, 2005)

EMPLOYMENT AGREEMENT (Filed With SEC on November 9, 2004)

EMPLOYMENT AGREEMENT (Filed With SEC on August 9, 2004)

EMPLOYMENT AGREEMENT (Filed With SEC on May 5, 2004)

Category

Industry

Companies

Contracts

CASI Pharmaceuticals, Inc. Contracts & Agreements